Trastuzumab plus docetaxel in HER-2/neu-positive prostate carcinoma: final results from the California Cancer Consortium Screening and Phase II Trial (Q38447818)

From Wikidata
Jump to navigation Jump to search
scientific article published on May 2004
edit
Language Label Description Also known as
English
Trastuzumab plus docetaxel in HER-2/neu-positive prostate carcinoma: final results from the California Cancer Consortium Screening and Phase II Trial
scientific article published on May 2004

    Statements

    Trastuzumab plus docetaxel in HER-2/neu-positive prostate carcinoma: final results from the California Cancer Consortium Screening and Phase II Trial (English)
    Primo N Lara
    Karen Giselle Chee
    Christopher Ruel
    Frederick J Meyers
    Carl R Gray
    Regina Gandour Edwards
    Paul H Gumerlock
    Przemyslaw Twardowski
    James H Doroshow
    2125-2131

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit